Chiara Barbieri
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience.
Journal: Infectious diseases and therapy
Published: September 26, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial.
Journal: The European respiratory journal
Published: January 05, 2022
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19.
Journal: Clinical therapeutics
Published: October 20, 2021
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern.
Journal: Infectious diseases and therapy
Published: July 06, 2021
COVID-19: general overview, pharmacological options and ventilatory support strategies.
Journal: Multidisciplinary respiratory medicine
Published: August 09, 2020
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation.
Journal: Critical care (London, England)
Published: July 12, 2020
Effectiveness of noninvasive ventilation in COVID-19 related-acute respiratory distress syndrome.
Journal: The clinical respiratory journal
Published: May 24, 2020
Pharmacologicaltreatment of COVID-19: lights and shadows.
Journal: Drugs in context
Published: April 13, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026